Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SOPH

Sophia Genetics (SOPH)

Sophia Genetics SA
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SOPH
DateTimeSourceHeadlineSymbolCompany
11/29/202112:02PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SOPHSophia Genetics SA
11/29/202110:33AMPR Newswire (US)SOPHiA GENETICS Hosts Symposium with GE Healthcare at RSNA 2021NASDAQ:SOPHSophia Genetics SA
11/29/202110:32AMPR Newswire (US)SOPHiA GENETICS Hosts Symposium with GE Healthcare at RSNA 2021NASDAQ:SOPHSophia Genetics SA
11/10/20217:13AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SOPHSophia Genetics SA
11/10/20217:00AMGlobeNewswire Inc.SOPHiA GENETICS Reports Third Quarter 2021 Financial Results and Raises 2021 GuidanceNASDAQ:SOPHSophia Genetics SA
11/01/20218:03AMPR Newswire (US)SOPHiA GENETICS Launches SOPHiA DDM™ for SureSelect Human All Exon v8NASDAQ:SOPHSophia Genetics SA
11/01/20218:03AMPR Newswire (US)SOPHiA GENETICS Launches SOPHiA DDM™ for SureSelect Human All Exon v8NASDAQ:SOPHSophia Genetics SA
10/28/20214:05PMGlobeNewswire Inc.SOPHiA GENETICS to Participate in Upcoming November Investor ConferencesNASDAQ:SOPHSophia Genetics SA
10/27/20214:05PMGlobeNewswire Inc.SOPHiA GENETICS to Report Third Quarter 2021 Financial Results on November 10, 2021NASDAQ:SOPHSophia Genetics SA
10/12/20213:36PMPR Newswire (US)SOPHiA GENETICS offers new genomic application for a deeper investigation of Mendelian diseasesNASDAQ:SOPHSophia Genetics SA
10/12/20213:29PMPR Newswire (Canada)SOPHiA GENETICS offers new genomic application for a deeper investigation of Mendelian diseasesNASDAQ:SOPHSophia Genetics SA
10/12/20213:29PMPR Newswire (US)SOPHiA GENETICS offers new genomic application for a deeper investigation of Mendelian diseasesNASDAQ:SOPHSophia Genetics SA
10/12/202110:58AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SOPHSophia Genetics SA
09/09/20217:00AMGlobeNewswire Inc.SOPHiA GENETICS Reports Second Quarter 2021 Financial Results and Issues 2021 GuidanceNASDAQ:SOPHSophia Genetics SA
08/30/20214:05PMGlobeNewswire Inc.SOPHiA GENETICS to Present at the Morgan Stanley 19th Annual Global Healthcare ConferenceNASDAQ:SOPHSophia Genetics SA
08/26/202112:43PMGlobeNewswire Inc.UPDATE – SOPHiA GENETICS to Report Second Quarter 2021 Financial Results on September 9, 2021NASDAQ:SOPHSophia Genetics SA
08/26/20219:00AMGlobeNewswire Inc.SOPHiA GENETICS to Report Second Quarter 2021 Financial Results on September 9, 2021NASDAQ:SOPHSophia Genetics SA
08/25/20214:01PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SOPHSophia Genetics SA
08/24/20219:50AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SOPHSophia Genetics SA
08/24/20219:00AMPR Newswire (US)Dasa expands partnership with SOPHiA GENETICS for the first decentralized cancer biomarker detection solution in Latin AmericaNASDAQ:SOPHSophia Genetics SA
08/19/202110:00AMEdgar (US Regulatory)Sec Staff Action/letter (sec Staff)NASDAQ:SOPHSophia Genetics SA
08/19/20219:57AMEdgar (US Regulatory)Sec Staff Action/letter (sec Staff)NASDAQ:SOPHSophia Genetics SA
07/27/20214:05PMGlobeNewswire Inc.SOPHiA GENETICS Announces Closing of $234 Million Initial Public Offering and $20 Million Private PlacementNASDAQ:SOPHSophia Genetics SA
07/22/20216:05PMGlobeNewswire Inc.SOPHiA GENETICS Announces Pricing of Initial Public OfferingNASDAQ:SOPHSophia Genetics SA
 Showing the most relevant articles for your search:NASDAQ:SOPH